These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24118922)

  • 1. Targeting p53 in melanoma.
    Box NF; Vukmer TO; Terzian T
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):8-10. PubMed ID: 24118922
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
    Lu M; Breyssens H; Salter V; Zhong S; Hu Y; Baer C; Ratnayaka I; Sullivan A; Brown NR; Endicott J; Knapp S; Kessler BM; Middleton MR; Siebold C; Jones EY; Sviderskaya EV; Cebon J; John T; Caballero OL; Goding CR; Lu X
    Cancer Cell; 2013 May; 23(5):618-33. PubMed ID: 23623661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
    Pandolfi S; Montagnani V; Lapucci A; Stecca B
    Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer.
    Kim DH
    Yonsei Med J; 2007 Aug; 48(4):694-700. PubMed ID: 17722244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
    Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
    Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
    J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis.
    Leach SD; Scatena CD; Keefer CJ; Goodman HA; Song SY; Yang L; Pietenpol JA
    Cancer Res; 1998 Aug; 58(15):3231-6. PubMed ID: 9699647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.
    Chae SW; Sohn JH; Kim DH; Choi YJ; Park YL; Kim K; Cho YH; Pyo JS; Kim JH
    Yonsei Med J; 2011 May; 52(3):445-53. PubMed ID: 21488187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy.
    Lu M; Miller P; Lu X
    FEBS Lett; 2014 Aug; 588(16):2616-21. PubMed ID: 24844434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation.
    Bonnefont J; Laforge T; Plastre O; Beck B; Sorce S; Dehay C; Krause KH
    Cell Death Differ; 2011 Feb; 18(2):293-303. PubMed ID: 20725088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    Biochem Biophys Res Commun; 2005 Apr; 329(2):713-8. PubMed ID: 15737644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection.
    Cho NH; Kang S; Hong S; An HJ; Choi YH; Jeong GB; Choi HK
    Cancer Lett; 2006 Feb; 232(2):170-8. PubMed ID: 16458113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase.
    Ohki R; Nemoto J; Murasawa H; Oda E; Inazawa J; Tanaka N; Taniguchi T
    J Biol Chem; 2000 Jul; 275(30):22627-30. PubMed ID: 10930422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.